Lenalidomide and Exfoliative rash - a phase IV clinical study of FDA data

Summary:

Exfoliative rash is reported as a side effect among people who take Lenalidomide (lenalidomide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Arsenic Trioxide, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Exfoliative rash when taking Lenalidomide. It is created by eHealthMe based on reports of 52,873 people who have side effects when taking Lenalidomide from the FDA, and is updated regularly.

What is Lenalidomide?

Lenalidomide has active ingredients of lenalidomide. eHealthMe is studying from 52,881 Lenalidomide users. Check the latest studies of Lenalidomide.

What is Exfoliative rash?

Exfoliative rash (scaly red generalized skin rash) is found to be associated with 361 drugs and 510 conditions by eHealthMe. Check the latest studies of Exfoliative rash.

On Jul, 28, 2026

52,873 people reported to have side effects when taking Lenalidomide.
Among them, 12 people (0.02%) have Exfoliative rash.

Could Lenalidomide cause Exfoliative rash?

Among these 12 people:

How long have people been on Lenalidomide when they have Exfoliative rash? *

What is the gender of people who have Exfoliative rash when taking Lenalidomide? *

female: 25 %
male: 75 %

What is the age of people who have Exfoliative rash when taking Lenalidomide? *

What are other drugs people take besides Lenalidomide? *

What are other side effects people have besides Exfoliative rash? *

Rashes (redness): 2 people, 16.67%
Rash Pruritic (redness with itching): 2 people, 16.67%
Rash Erythematous (redness of the skin): 2 people, 16.67%
Diarrhea: 2 people, 16.67%
Weakness: 1 person, 8.33%
Fatigue (feeling of tiredness): 1 person, 8.33%
Constipation: 1 person, 8.33%
Dehydration (dryness resulting from the removal of water): 1 person, 8.33%
Drug Eruption (adverse drug reaction of the skin): 1 person, 8.33%
Drug Ineffective: 1 person, 8.33%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 7 people, 58.33%
Splenic Marginal Zone Lymphoma (cancer of the lymph nodes spleen): 1 person, 8.33%
Lymphoma (cancer that begins in immune system cells): 1 person, 8.33%
Adult T-Cell Lymphoma/leukaemia (cancer of the immune system's own t-cells): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Lenalidomide and have Exfoliative rash?

- Check whether Exfoliative rash is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lenalidomide:

Lenalidomide (52,881 reports)

Browse all side effects of Lenalidomide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Exfoliative rash:

Exfoliative rash (361 drugs)

Browse all the conditions that are associated with Exfoliative rash:

Exfoliative rash (510 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lenalidomide (the active ingredients of Lenalidomide) and Lenalidomide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.